EQUITIES

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

vd-icon_Currency_CashUSD

$243.6bn
Equities Assets Under Management

vd-icon_People_3_Group v3

148
Equities Investment
Professionals

vd-icon_Bulleye_Target v3

19
Average Years’ Financial
Industry Experience

As at June 30, 2025

<span class="notranslate">no data</span>

$243.6bn
Equities Assets Under Management

148
Equities Investment
Professionals

19
Average Years’ Financial
Industry Experience

As at June 30, 2025

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

Global Life Sciences

By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.

Global Technology Leaders

A global approach to investing in technology companies from a highly experienced team

Insights

Chart to Watch: Biotech bounces back

Optimism is returning to the biotech space, and we see durable drivers behind the recent performance recovery.

Quick View: Political upheaval and budgetary uncertainty leaves France at a crossroads

Following French Prime Minister François Bayrou’s loss of a confidence vote, Robert-Schramm Fuchs explores the implications for investors and explains why he remains positive on Europe.

Productivity lift: A supportive backdrop for earnings growth

How corporate efficiency is supporting profitability and earnings growth.